Standard of postoperative risk assessment for resectable gastrointestinal stromal tumor and its evaluation.
- Author:
Xiao-bo LIANG
1
Author Information
1. Department of Anus and Intestine Surgery, Shanxi Tumor Hospital, Taiyuan 030013, China. liangxiaobo@medmail.com.cn
- Publication Type:Journal Article
- MeSH:
Gastrointestinal Neoplasms;
surgery;
Gastrointestinal Stromal Tumors;
surgery;
Humans;
Neoplasm Recurrence, Local;
Risk Assessment
- From:
Chinese Journal of Gastrointestinal Surgery
2013;16(3):204-207
- CountryChina
- Language:Chinese
-
Abstract:
Surgery is the only possible cure protocol of gastrointestinal stromal tumor (GIST). But the risk of recurrence exists constantly. Risk assessment of relapse is very important to guide the targeted adjuvant therapy and predict the prognosis. Although the variables and grading in the risk assessment of recurrence after complete resection of primary local GIST have been identified, but either the F/NIH consensus, AFIP standards, modified NIH standards, or risk identification methods attempted to apply mathematical calculation model in recent years, including Jason S Gold risk nomogram, Rossi nomogram, Joensuu high Hotline Dengjun, are short of long-term, large-scale clinical trials without selection bias. Therefore, recurrence risk probability cannot be predicted accurately.
